Publications

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges.

Gomes, M; Latimer, N; Soares, M; Dias, S; Baio, G; Freemantle, N; Dawoud, D; Wailoo, A; GRIEVE, R;

2022

PharmacoEconomics, (2022).40 6 10.1007/s40273-022-01141-x.

A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis.

Ling, X; Gabrio, A; MASON, A; Baio, G;

2022

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2022).25 9 10.1016/j.jval.2022.02.009.

Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.

Ferrari, G; TORRES-RUEDA, S; Chirwa, E; Gibbs, A; Orangi, S; Barasa, E; Tawiah, T; Dwommoh Prah, RK; Hitimana, R; Daviaud, E; Kapapa, E; Dunkle, K; Heise, L; STERN, E; Chatterji, S; Omondi, B; Ogum Alangea, D; Karmaliani, R; Maqbool Ahmed Khuwaja, H; Jewkes, R; Watts, C; VASSALL, A;

2022

PLOS MEDICINE, (2022).19 3 10.1371/journal.pmed.1003827.

Developing a tool to assess the skills to perform a health technology assessment.

Bidonde, J; Meneses-Echavez, JF; Asare, B; Chola, L; Gad, M; Heupink, LF; Peacocke, EF; IDSI Ghana HTA collaboration Group,;

2022

BMC medical research methodology, (2022).22 1 10.1186/s12874-022-01562-4.

The economics of vision impairment and its leading causes: A systematic review.

MARQUES, AP; RAMKE, J; CAIRNS, J; Butt, T; Zhang, JH; Jones, I; Jovic, M; Nandakumar, A; Faal, H; Taylor, H; BASTAWROUS, A; Braithwaite, T; Resnikoff, S; Khaw, PT; Bourne, R; GORDON, I; Frick, K; BURTON, MJ;

2022

EClinicalMedicine, (2022).46, 10.1016/j.eclinm.2022.101354.

Social determinants of the changing tuberculosis prevalence in Việt Nam: Analysis of population-level cross-sectional studies.

FOSTER, N; Nguyen, HV; Nguyen, NV; Nguyen, HB; Tiemersma, EW; Cobelens, FG J; QUAIFE, M; HOUBEN, RM G J;

2022

PLOS Medicine, (2022).19 3 10.1371/journal.pmed.1003935.

Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children.

Li, X; Bilcke, J; Vázquez Fernández, L; Bont, L; Willem, L; Wisløff, T; JIT, M; Beutels, P; REspiratory Syncytial virus Consortium in EUrope (,;

2022

The Journal of infectious diseases, (2022).226 Suppl 1 10.1093/infdis/jiac064.

Assessing the potential of wearable health monitors for health system strengthening in low- and middle-income countries: a prospective study of technology adoption in Cambodia.

LIVERANI, M; Ir, P; PEREL, P; KHAN, M; BALABANOVA, D; WISEMAN, V;